4//SEC Filing
Brown Victoria L. 4
Accession 0001127602-21-003232
CIK 0001492422other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 4:35 PM ET
Size
7.0 KB
Accession
0001127602-21-003232
Insider Transaction Report
Form 4
Brown Victoria L.
Program Team Lead
Transactions
- Award
Common Stock
2021-01-28+5,000→ 8,928 total - Award
Stock Option (Right to Buy)
2021-01-28+30,000→ 30,000 totalExercise: $44.90Exp: 2031-01-27→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]This Restricted Stock Units grant will vest 25% annually over four years from grant date, subject to continued service.
- [F2]Includes 321 shares from 11/30/21 ESPP Purchase.
- [F3]This stock option will vest as to 25% of the shares underlying the options on the first anniversary of the grant, with the remaining 75% of the shares underlying the options vesting in equal monthly installments thereafter through the fourth anniversary of the grant, subject to continued service.
Documents
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeother
Related Parties
1- filerCIK 0001810475
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 4:35 PM ET
- Size
- 7.0 KB